Chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of Duchenne muscular dystrophy
Calpains likely play a role in the pathogenesis of Duchenne muscular dystrophy (DMD). Accordingly, calpain inhibition may provide therapeutic benefit to DMD patients. In the present study, we sought to measure benefit from administration of a novel calpain inhibitor, C101, in a canine muscular dystr...
Saved in:
Main Authors: | Martin K Childers (Author), Janet R Bogan (Author), Daniel J Bogan (Author), Hansel eGreiner (Author), Melanie eHolder (Author), Robert eGrange (Author), Joe N Kornegay (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989) -
Prednisone in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1991) -
Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy
by: Ryan D. Wuebbles, et al.
Published: (2013) -
Delay in Diagnosis of Duchenne Muscular Dystrophy
by: Vamshi K Rao, et al.
Published: (2015) -
Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021)